Funding for this research was provided by:
National Institute for Occupational Safety and Health (U19 OH008861)
Bill and Melinda Gates Foundation
Eli Lilly and Company
Brigham and Women's Hospital
Received: 11 March 2018
Accepted: 4 December 2018
First Online: 11 December 2018
Ethics approval and consent to participate
: Institutional Review Boards at Harvard School of Public Health (Boston, Massachusetts) and the Siberian State Medical University (Tomsk, Russia) approved the parent study. Secondary analysis was reviewed and declared exempt by the Institutional Review Board at Northeastern University (Boston, Massachusetts). Patients provided written informed consent prior to the initiation of TB therapy.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.